Cadence Pharmaceuticals™

Contact Us

Investor Relations contact:
Cadence Pharmaceuticals
858-436-1400
ir@cadencepharm.com

Questions for the Investor Relations Department can also be submitted through the form below. Fields marked with an * are required.

 
 
 
 
 
 
This helps Cadence Pharmaceuticals, Inc. prevent automated submissions.
 
Print page Print
Email page Email


Stock Quote
CADX - (NASDAQ)
$8.70   + 0.03
Nov 20, 2009
4:12 PM ET

Quotes delayed at
least 20 minutes.
Information provided
by eSignal.